GI & Endoscopy

The administrator of a Colorado GI practice said the practice is starting to see its elective procedure volumes return, in a May 7 article in the Greeley Tribune.

Here are six updates from gastroenterology companies and practices from the past week:

Motus GI secured a U.S. patent for its Pure-Vu System's sensing technology and suction control features.

Medicare beneficiaries may engage with a multi-target stool DNA test better than a fecal immunochemical test, according to a study debuted digitally at Digestive Disease Week 2020.

Thompson Health Gastroenterology is relocating to a new outpatient clinic May 4, the Daily Messenger reports.

The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients.

CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity.

Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic, gastroenterologist Paul Berggreen, MD, told Medscape Medical News.

RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 27-May 1: